timeline, page-8

  1. 109 Posts.
    lightbulb Created with Sketch. 3
    As most on this forum would know, there is no short answer to this question and no definitive answer. There are many variables in the equation. Whether or not the the trials are afforded orphan drug status. The size of the trials in terms of how many subjects are required (sadly, this means women with quite often terminal cervical cancer, what outcomes the drug has stated its aiming for. Also whether or not the FDA sends PRR back to the drawing board to redo any trial stages if they are not happy with techniques or results etc. To a lesser extent now, funding may also play an important part in how long this thing takes to get to commercialisation. I don't think even Martin could give a definitive answer to be honest.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
24.5¢
Change
0.005(2.08%)
Mkt cap ! $357.7M
Open High Low Value Volume
24.5¢ 24.5¢ 24.0¢ $66.50K 272.6K

Buyers (Bids)

No. Vol. Price($)
25 465765 24.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.5¢ 636844 48
View Market Depth
Last trade - 15.17pm 02/07/2025 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.